Hainan Haili Pharmaceutical Co., Ltd.
-
Founded in:
1992-12-30 -
Country:
China -
Address:
No. 9 Haili Road, Yonggui Industrial Development Zone, Xiuying District, Haikou City -
Tax NO.:
9146000020133914XP -
Registered Funds:
60 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 1，1-DIMETHYLBIGUANIDE HYDROCHLORIDE |
This product is a hypoglycemic drug that can reduce fasting and postprandial hyperglycemia in patients with type 2 diabetes. Its hypoglycemic mechanism is: 1. Increase the sensitivity of peripheral tissues to insulin and increase insulin-mediated glucose utilization; 2. Increase the utilization of glucose by non-insulin-dependent tissues, such as the brain, blood cells, renal medulla, intestines, skin, etc.; 3. Inhibit hepatic gluconeogenesis and reduce hepatic glucose output; 4. Inhibit intestinal wall cells from taking up glucose. Unlike insulin, this product does not promote fat synthesis and has no obvious hypoglycemic effect on normal people. It generally does not cause hypoglycemia when used alone for type 2 diabetes.
More
This product is a hypoglycemic drug that can reduce fasting and postprandial hyperglycemia in patients with type 2 diabetes. Its hypoglycemic mechanism is: 1. Increase the sensitivity of peripheral tissues to insulin and increase insulin-mediated glucose utilization; 2. Increase the utilization of glucose by non-insulin-dependent tissues, such as the brain, blood cells, renal medulla, intestines, skin, etc.; 3. Inhibit hepatic gluconeogenesis and reduce hepatic glucose output; 4. Inhibit intestinal wall cells from taking up glucose. Unlike insulin, this product does not promote fat synthesis and has no obvious hypoglycemic effect on normal people. It generally does not cause hypoglycemia when used alone for type 2 diabetes. |
15537-72-1 | 55 |